N@N

Gary Nachman Maintained (ABBV) at Buy with Increased Target to $153 on, Jan 12th, 2022

Gary Nachman of BMO Capital, Maintained "AbbVie Inc." (ABBV) at Buy with Increased Target from $134 to $153 on, Jan 12th, 2022.

Gary has made no other calls on ABBV in the last 4 months.

There are 11 other peers that have a rating on ABBV. Out of the 11 peers that are also analyzing ABBV, 3 agree with Gary's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Chris Shibutani of "Goldman Sachs" Initiated at Hold and Held Target at $113 on, Friday, December 17th, 2021
• Luisa Hector of "Berenberg" Maintained at Hold and Held Target at $105 on, Wednesday, November 24th, 2021
• Carter Gould of "Barclays" Maintained at Hold with Increased Target to $118 on, Monday, November 1st, 2021

These are the ratings of the 8 analyists that currently disagree with Gary

---

• Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $154 on, Wednesday, January 5th, 2022
• Aaron Gal of "Bernstein" Maintained at Buy with Increased Target to $155 on, Monday, January 3rd, 2022
• Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $160 on, Monday, January 3rd, 2022
• Mohit Bansal of "Wells Fargo" Initiated at Buy and Held Target at $165 on, Thursday, December 9th, 2021
• Navin Jacob of "UBS" Maintained at Strong Buy with Increased Target to $129 on, Monday, November 29th, 2021
• Justin Smith of "Societe Generale" Upgraded from Hold to Strong Buy and Held Target at $172 on, Tuesday, November 23rd, 2021
• Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $124 on, Monday, November 1st, 2021
• Geoffrey Porges of "SVB Leerink" Maintained at Buy with Decreased Target to $135 on, Monday, November 1st, 2021

Contributing Sources

---